4.5 Article

Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease

期刊

LIPIDS IN HEALTH AND DISEASE
卷 20, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12944-021-01453-5

关键词

Nonalcoholic fatty liver disease; Abnormal glucose metabolism; FibroScan; Liver stiffness measurement; Fibrosis

资金

  1. Shanghai Municipal Population and Family Planning Commission [201740092]
  2. Shanghai TCM Development Office [ZY (2018-2020)-FWTX3019]
  3. Foundation of Fudan University, China [20520133483]
  4. Science and Technology Commission of Shanghai Municipality [20ZR1410200]
  5. Xiamen Municipal Bureau of Science and Technology [3502Z20209043]
  6. Special Project of Integrating Traditional Chinese and Western Medicine in Shanghai General Hospital from the Shanghai Municipal Population and Family Planning Commission

向作者/读者索取更多资源

This study evaluated the diagnostic accuracy of LSM in NAFLD patients with abnormal glucose metabolism. HbA1c and ALT were found to be independently associated with the LSM value, and certain characteristics may affect the LSM values.
Background The performance of liver stiffness measurements (LSMs) obtained using FibroScan can be affected by several factors, and cut-off values are different for fibrosis caused by various aetiologies. The study aims to evaluate the diagnostic accuracy of LSM in nonalcoholic fatty liver disease (NAFLD) patients with abnormal glucose metabolism and investigate whether the LSM value would be affected by metabolic indicators. Methods The study involved 91 NAFLD patients with abnormal glucose metabolism who underwent liver biopsy. The diagnostic accuracy of LSM value was evaluated by the receiver operator characteristic (ROC) curves, with the biopsy results taken as the gold standard. Multivariate linear regression and subgroup analysis were performed to determine the correlated indicators. Results The areas under the ROC curves (AUROCs) of LSM values for detecting fibrosis stage >= 1, 2, 3 and 4 were 0.793 (95% confidence interval [CI]: 0.695-0.871), 0.764 (95% CI: 0.663-0.846), 0.837 (95% CI: 0.744-0.906) and 0.902 (95% CI: 0.822-0.955), with cut-off values of 6.3, 7.6, 8.3 and 13.8 kPa, respectively. Multivariate linear regression demonstrated that haemoglobin A1c (HbA1c, beta = 0.205, P = 0.026) and alanine aminotransferase (ALT, beta = 0.192, P = 0.047) were independently associated with the LSM value after adjustment for fibrosis stage, ballooning and inflammation grade from liver biopsy. Subgroup analysis demonstrated that LSM values were slightly higher in patients with HbA1c >= 7% than in those with HbA1c < 7% and in patients with body mass index (BMI) >= 30 kg/m(2) than in those with BMI < 30 kg/m(2). Conclusions FibroScan was valuable for the evaluation of liver fibrosis in NAFLD patients with abnormal glucose metabolism. FibroScan is recommended to evaluate severe fibrosis, especially to exclude advanced fibrosis. Glucose metabolism state may affect LSM values.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据